Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.38 |
| ▸ | ITPR3 | Q14573 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | NT5E | P21589 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | MMP14 | P50281 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12964684 | 0.95 | ALB (0.44) | ALBMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL4403233 | 0.94 | GSTP1 (0.41) | ALBMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL18950720 | 0.90 | GSTP1 (0.38) | ALBMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL4403236 | 0.89 | GSTP1 (0.45) | ALBMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL23758534 | 0.86 | GSTP1 (0.44) | ALBMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL13881238 | 0.86 | GSTP1 (0.46) | ALBMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL13193883 | 0.85 | GSTP1 (0.43) | ALBMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL12951612 | 0.85 | GSTP1 (0.42) | ALBMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL12925030 | 0.84 | MAPT (0.40) | MAPTMEN1ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL12085744 | 0.84 | LMNA (0.39) | MAPTMEN1ALDH1A1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120258470-A1 | COMPOSITIONS COMPRISING A DEHALOGENASE SUBSTRATE AND A RADIONUCLIDE AND METHODS OF USE | PROMEGA CORPORATION (US) | 2012-10-11 | — | — | US | disclosed |
| US-8202700-B2 | Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule | PROMEGA CORPORATION (US) | 2012-06-19 | — | — | US | disclosed |
| US-RE42931-E1 | Covalent tethering of functional groups to proteins | PROMEGA CORPORATION (US) | 2011-11-15 | — | — | US | disclosed |
| US-20110207195-A1 | METHOD OF IMMOBILIZING A PROTEIN OR MOLECULE VIA A MUTANT DEHALOGENASE THAT IS BOUND TO AN IMMOBILIZED DEHALOGENASE SUBSTRATE AND LINKED DIRECTLY OR INDIRECTLY TO THE PROTEIN OR MOLECULE | PROMEGA CORPORATION (US) | 2011-08-25 | — | — | US | disclosed |
| US-20080274488-A1 | Covalent tethering of functional groups to proteins and substrates therefor | PROMEGA CORPORATION | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120258470-A1 | COMPOSITIONS COMPRISING A DEHALOGENASE SUBSTRATE AND A RADIONUCLIDE AND METHODS OF USE | HDHD5, DNPH1, DOHH | ALB 1964/4885MAPT 4087/4885MEN1 2134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.